CVR: 40738223
Secondary names: TPT ApS
Tetra Pharm Technologies ApS is a Danish company of the type Anpartsselskab based in København S, founded in 2019. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Jesper Breum and Martin Stefan Rose. The company's owners include RUMP INVEST ApS, Breum Holding EST. 2016 ApS and BrainFrame ApS. In 2025, the company reported a gross profit of DKK -17,669,007 and a net result of DKK -52,589,605 compared with DKK -55,213,708 the year before. Equity amounted to DKK -25,844,292.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er at være biotekselskab, investering samt enhver beslægtet virksomhed efter ledelsens beslutning.
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationCompared to 129 companies in Fremstilling af farmaceutiske præparater
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Tetra Pharm Technologies ApS has published its annual report for 2025. Gross profit came to DKK -17,669,007, and the net result was DKK -52,589,605.
Contact info changed: new phone: 29737073, new email: [email protected], new website: https://www.tetrapharm.eu/ (July 8, 2026).
As of July 1, 2026, Rolf Sass Sørensen has joined the board of directors of Tetra Pharm Technologies ApS.
Contact info changed: new phone: 29737073, new email: [email protected], new website: https://www.tetrapharm.eu/ (June 4, 2026).
Contact info changed: new phone: 29737073, new email: [email protected], new website: https://www.tetrapharm.eu/ (May 28, 2026).
As of May 1, 2026, Claus Berner Nielsen has joined the board of directors of Tetra Pharm Technologies ApS.
As of May 1, 2026, Jesper Breum has joined the board of directors of Tetra Pharm Technologies ApS.
As of May 1, 2026, Søren Maarssø has joined the board of directors of Tetra Pharm Technologies ApS.
As of May 1, 2026, Lars Frøvang Thomsen has left the board of directors of Tetra Pharm Technologies ApS.
As of May 1, 2026, Martin Stefan Rose has left the board of directors of Tetra Pharm Technologies ApS.
As of May 1, 2026, RUMP INVEST ApS is registered as an owner of Tetra Pharm Technologies ApS with an ownership share of 5%.
As of May 1, 2026, Nesroht Holding ApS is registered as an owner of Tetra Pharm Technologies ApS with an ownership share of 25%.
As of April 30, 2026, Jesper Breum has left the board of directors of Tetra Pharm Technologies ApS.
As of April 8, 2026, MARTINSEN STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Tetra Pharm Technologies ApS.
Contact info changed: new phone: 29737073, new email: [email protected], new website: https://www.tetrapharm.eu/ (March 30, 2026).
As of October 10, 2025, Breum Holding EST. 2016 ApS is registered as an owner of Tetra Pharm Technologies ApS with an ownership share of 20%.
As of October 10, 2025, BrainFrame ApS is registered as an owner of Tetra Pharm Technologies ApS with an ownership share of 20%.
Tetra Pharm Technologies ApS has published its annual report for 2024. Gross profit came to DKK 1,460,638, and the net result was DKK -55,213,708.
As of May 23, 2025, Søren Rose has left the board of directors of Tetra Pharm Technologies ApS.
As of April 1, 2025, Jesper Breum has joined the board of directors of Tetra Pharm Technologies ApS.
As of March 31, 2025, Jesper Breum has left the board of directors of Tetra Pharm Technologies ApS.
As of March 28, 2025, Nikolay Tretiyakov has left the board of directors of Tetra Pharm Technologies ApS.
Tetra Pharm Technologies ApS has published its annual report for 2023. Gross profit came to DKK 584,758, and the net result was DKK -32,946,869.
As of April 22, 2024, Lars Frøvang Thomsen has joined the board of directors of Tetra Pharm Technologies ApS.
As of April 22, 2024, Per Mogens Bugge has left the board of directors of Tetra Pharm Technologies ApS.
Tetra Pharm Technologies ApS has published its annual report for 2022. Gross profit came to DKK -510,296, and the net result was DKK -7,767,688.
As of August 1, 2022, OLE GS HOLDING ApS is registered as an owner of Tetra Pharm Technologies ApS with an ownership share of 5%.
Tetra Pharm Technologies ApS has published its annual report for 2021. Gross profit came to DKK 3,208,286, and the net result was DKK 305,591.
As of January 12, 2022, is registered as an owner of Tetra Pharm Technologies ApS with an ownership share of 5%.
As of September 3, 2021, Per Mogens Bugge has joined the board of directors of Tetra Pharm Technologies ApS.
As of September 3, 2021, Jesper Breum has joined the board of directors of Tetra Pharm Technologies ApS.
As of September 3, 2021, Martin Stefan Rose has joined the board of directors of Tetra Pharm Technologies ApS.
As of September 3, 2021, Søren Rose has joined the board of directors of Tetra Pharm Technologies ApS.
As of September 3, 2021, Nikolay Tretiyakov has joined the board of directors of Tetra Pharm Technologies ApS.
Tetra Pharm Technologies ApS has published its interim report for the period August 26, 2019 – December 31, 2020.
As of December 1, 2020, Jesper Breum is registered as director of Tetra Pharm Technologies ApS.
As of August 26, 2019, Martin Stefan Rose is registered as director of Tetra Pharm Technologies ApS.
Tetra Pharm Technologies ApS was founded on August 26, 2019.
Companies in the same industry and area
CVR 41040351
CVR 26524938
CVR 42376558
CVR 29023875
CVR 44291908
companydata.dk